Purchases and Sales Made in Q3 2024 in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during Q3 2024. The information is specifically focused on institutions that hold shares of Protagonist Therapeutics, Inc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-226K- 11.07% |
$7.62M - $10.7M
|
1.81M
$70.8M
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-257K- 44.88% |
$8.66M - $12.2M
|
315K
$12.3M
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-315K- 88.65% |
$10.6M - $14.9M
|
40.4K
$1.57M
|
|
Nov 14, 2024
Q3 2024
|
Kynam Capital Management, LP
Princeton, NJ |
SELL
|
- |
-344K- 42.95% |
$11.6M - $16.3M
|
456K
$17.8M
|
|
Nov 14, 2024
Q3 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-356K- 43.26% |
$12M - $16.8M
|
467K
$18.2M
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-391K- 63.39% |
$13.2M - $18.5M
|
226K
$8.8M
|
|
Nov 14, 2024
Q3 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-623K- 38.82% |
$21M - $29.5M
|
981K
$38.3M
|
|
Nov 14, 2024
Q3 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-695K- 76.38% |
$23.4M - $32.9M
|
215K
$8.38M
|
|
Nov 13, 2024
Q3 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-788K- 86.77% |
$26.6M - $37.3M
|
120K
$4.69M
|
|
Nov 14, 2024
Q3 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-800K- 40.0% |
$27M - $37.9M
|
1.2M
$46.9M
|
|
Nov 12, 2024
Q3 2024
|
Cowen And Company, LLC
|
SELL
|
- |
-841K- 71.16% |
$28.4M - $39.8M
|
341K
$13.3M
|
|
Nov 14, 2024
Q3 2024
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-1.47M- 44.26% |
$49.5M - $69.5M
|
1.85M
$72.2M
|